Victoria Valerievna Firstova (Victoria V Firstova)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Replacement Therapy

Botulinum Toxin

Allergic Rhinitis

Top Venues

BioImpacts : BI

This page only lists publications with an associated author ORCID identifier.

Publications

Natalia A Zeninskaya, Alena K Ryabko, Maksim A Marin, Tatyana I Kombarova, Maria A Shkuratova, Methun M Rogozin, Marina V Silkina, Yana O Romanenko, Tatiana A Ivashchenko, Igor G Shemyakin, Victoria Valerievna Firstova
Selection of Candidate Monoclonal Antibodies for Therapy of Botulinum Toxin Type A Intoxications. Toxins 16 (7) (2024)
Natalia A Zeninskaya, Alena K Ryabko, Maksim A Marin, Tatyana I Kombarova, Maria A Shkuratova, Methun M Rogozin, Marina V Silkina, Yana O Romanenko, Tatiana A Ivashchenko, Igor G Shemyakin, Victoria Valerievna Firstova
Selection of Candidate Monoclonal Antibodies for Therapy of Botulinum Toxin Type A Intoxications. Toxins 16 (7) (2024)
Natalia A Zeninskaya, Alena K Ryabko, Maksim A Marin, Tatyana I Kombarova, Maria A Shkuratova, Methun M Rogozin, Marina V Silkina, Yana O Romanenko, Tatiana A Ivashchenko, Igor G Shemyakin, Victoria Valerievna Firstova
Selection of Candidate Monoclonal Antibodies for Therapy of Botulinum Toxin Type A Intoxications. Toxins 16 (7) (2024)
Marina Vladimirovna Silkina, Alena Sergeevna Kartseva, Alena Konstantinovna Riabko, Mariia Aleksandrovna Makarova, Metkhun Madibronovich Rogozin, Yana Olegovna Romanenko, Igor Georgievich Shemyakin, Ivan Alekseevich Dyatlov, Victoria Valerievna Firstova
New approach to generating of human monoclonal antibodies specific to the proteolytic domain of botulinum neurotoxin A. BioImpacts : BI 14 (4) (2023)
Marina Vladimirovna Silkina, Alena Sergeevna Kartseva, Alena Konstantinovna Riabko, Mariia Aleksandrovna Makarova, Metkhun Madibronovich Rogozin, Yana Olegovna Romanenko, Igor Georgievich Shemyakin, Ivan Alekseevich Dyatlov, Victoria Valerievna Firstova
New approach to generating of human monoclonal antibodies specific to the proteolytic domain of botulinum neurotoxin A. BioImpacts : BI 14 (4) (2023)